Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 17, 2017
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
Journal: The New England journal of medicine
Published: June 11, 2015
CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas.
Journal: Journal of neuropathology and experimental neurology
Published: April 09, 2015
The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: February 20, 2013
Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 12, 2013
The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features.
Journal: Journal of neuro-oncology
Published: November 13, 2012
PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma.
Journal: Brain pathology (Zurich, Switzerland)
Published: October 24, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026